Howard Horn
Director of Finance/CFO chez ULTRAGENYX PHARMACEUTICAL INC.
Fortune : 7 M $ au 31/03/2024
Profil
Howard Horn est directeur financier, secrétaire et agent comptable principal chez Vir Biotechnology, Inc. M. Horn a précédemment occupé le poste de vice-président de la planification des activités chez Biogen, Inc. et d'analyste chez UBS Securities LLC. M. Horn a obtenu un diplôme de premier cycle à l'Université de Princeton et un MBA à la Wharton School de l'Université de Pennsylvanie.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2024 | 99 766 ( 0,12% ) | 5 M $ | 31/03/2024 | |
VIR BIOTECHNOLOGY, INC.
0,14% | 03/04/2023 | 189 462 ( 0,14% ) | 2 M $ | 31/03/2024 |
Postes actifs de Howard Horn
| Sociétés | Poste | Début |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Director of Finance/CFO | 16/10/2023 |
Anciens postes connus de Howard Horn
| Sociétés | Poste | Fin |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Director of Finance/CFO | 27/03/2023 |
| BIOGEN INC. | Corporate Officer/Principal | 01/10/2016 |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Analyst-Equity | - |
Formation de Howard Horn
| Princeton University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
UBS Securities LLC
UBS Securities LLC Investment Banks/BrokersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Finance |
